Elevance Health Inc (LTS:0HG8)
$ 372.93 3.0083 (0.82%) Market Cap: 86.49 Bil Enterprise Value: 105.88 Bil PE Ratio: 13.63 PB Ratio: 1.99 GF Score: 85/100

Elevance Health Inc at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 05:00PM GMT
Release Date Price: $472.48 (-0.11%)
Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Well, good morning, everyone. Thanks again for joining us at our conference. My name is Nathan Rich. I cover the managed space here at Goldman Sachs. We're very happy to have Elevance Health here with us today. I'll do a quick round of introductions and then we can get into questions.

So to my left, Felicia Norwood, President of the Government Business; then we have Morgan Kendrick, President of the Commercial Business; and Steve Tanal from Investor Relations.

Questions & Answers

Nathan Allen Rich;Stephen Vartan Tanal<
Goldman Sachs Group, Inc., Research Division - Research Analyst

I think maybe starting at a high level, could you maybe give us your view of how utilization has trended to start this year? One of the themes we heard about yesterday is continued kind of robust demand for procedures, and I'd just be curious from your perspective, what you're seeing and any notable differences across the lines of business that you oversee.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot